Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that data from its Lymphoseek® (technetium Tc 99m tilmanocept) Injection studies in patients with breast cancer, melanoma or head and neck cancer are being presented at the Joint International Oncology Congress (JIOC) from May 27-29, 2013 in San Francisco, CA.
Help employers find you! Check out all the jobs and post your resume.
